Article Text

PDF

128 Outcomes of 847 childhood-onset systemic lupus erythematousus patients in three age groups
  1. L Campos1,
  2. S Lopes2,
  3. N Gormezano2,
  4. R Gomes3,
  5. N Aikawa2,
  6. R Pereira2,
  7. M Terreri4,
  8. C Magalhaes5,
  9. E Okuda6,
  10. A Sakamoto4,
  11. A Sallum3,
  12. S Appenzeller7,
  13. V Ferriani8,
  14. C Barbosa9,
  15. S Lotufo10,
  16. L Andrade4,
  17. E Bonfa2 and
  18. C Silva3
  1. 1SAO PAULO, Brazil
  2. 2Faculdade de Medicina da Universidade de São Paulo, Division of Rheumatology, Sao Paulo, Brazil
  3. 3Children’s Institute- Faculdade de Medicina da Universidade de São Paulo, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  4. 4Universidade Federal de São Paulo, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  5. 5São Paulo State University UNESP – Faculdade de Medicina de Botucatu, Paediatric Rheumatology Division, Sao Paulo, Brazil
  6. 6Irmandade da Santa Casa de Misericórdia de São Paulo, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  7. 7State University of Campinas UNICAMP, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  8. 8Ribeirão Preto Medical School – University of São Paulo, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  9. 9Hospital Infantil Darcy Vargas, Paediatric Rheumatology Unit, Sao Paulo, Brazil
  10. 10Hospital Menino Jesus, Paediatric Rheumatology Unit, Sao Paulo, Brazil

Abstract

Background and aims To assess outcomes of childhood systemic lupus erythematosus (cSLE) in three different age groups evaluated at last visit: group A early-onset disease(<6 years), group B school age(≥6and<12 years) and group C adolescent(≥12and<18 years).

Methods Observational cohort study of 10 Paediatric Rheumatology centres, including 847 cSLE patients.

Results Group A had 39 (4%), B 395 (47%) and C 413 (49%). Median disease duration was higher in group A compared to groups B and C[8.3 (0.1–23.4) vs. 6.2 (0–17) vs. 3.3 (0–14.6) years, p<0.0001]. The median SLICC/ACR-DI[0 (0–9) vs. 0 (0–6) vs. 0 (0–7), p=0.065] was comparable in all groups. Further analysis of organ/system damage revealed that frequencies of neuropsychiatric(21% vs. 10% vs. 7%, p=0.007), skin (10% vs. 1% vs. 3%, p=0.002) and peripheral vascular involvements(5% vs. 3% vs. 0.3%, p=0.008) were more frequent in group A compared to B and C. Frequencies of severe cumulative lupus manifestations such as nephritis, thrombocytopenia and autoimmune hemolytic anaemia were similar in all groups(p>0.05). Mortality rate was higher in group A compared to groups B and C(15% vs. 10% vs. 6%, p=0.028). Out of 69 deaths, 33/69 (48%) occurred within the first two years after diagnosis. Infections accounted for 54/69 (78%) of the deaths and 38/54 (70%) had concomitant disease activity.

Conclusions This large multicenter study provided evidence that early-onset cSLE group had distinct outcomes, with higher mortality rate and neuropsychiatric/vascular/skin organ damages in spite of comparable frequencies of severe cumulative lupus manifestations. We also identified that overall death in cSLE patients was an early event mainly attributed to infection associated with disease activity.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.